RNA medicines can target any gene or protein in humans and so can be used to treat diseases that cannot be treated by conventional drugs such as small molecules and biologics.
Our bodies and cells are made up of many different proteins. Diseases occur when genes and proteins inside our bodies malfunction. DNA contains the genetic code needed for cells to make proteins. Various types of RNA, including messenger RNA (mRNA), small interfering RNA (siRNA) and microRNA, work together to control how the genes contained in our DNA are translated into proteins.
Arcturus’ proprietary UNA Oligomer™ and LUNAR™ delivery technologies can be used to make all classes of RNA medicines safe and effective.
NOVA scienceNOW : 8 – RNAi – click to view
May 30, 2017
Arcturus Therapeutics to Receive Up to $3 Million from Cystic Fibrosis Foundation Therapeutics to Advance a Novel LUNAR-Formulated mRNA CFTR Therapeutic
August 23, 2017
Pictures by Ernst and Young (Finalists for the Entrepreneur Of The Year 2017 Award® in San Diego)
August 9, 2017
Arcturus Therapeutics in the list of Cystic Fibrosis Key Companies